A Phase 2, multicenter, open-label, long-term safety study of LP352 in subjects with developmental and epileptic encephalopathy who completed Study LP352-201 and are candidates for continuous treatment for up to 52 weeks

Project: Research

Project Details

Project Description

HREC Reference Number: HREC/23/QCHQ/94666
Monash Health Local Reference: RES-23-0000-427X
StatusActive
Effective start/end date25/07/23 → 24/07/28

Clinical Trial Phase

  • Phase II